+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Activated Carbon for Pharma & Healthcare Market Size, Share & Trends Analysis Report by Form (Powdered, Granular), Application (API Production, Finished Drug Production), and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 132 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 6098213
Description Jump to:
The Activated Carbon for Pharma & Healthcare Market was valued at USD 450.1 million in 2024, and is projected to reach USD 652.1 million by 2030, rising at a CAGR of 6.30%. The demand for activated carbon in the pharmaceutical and healthcare sectors continues to grow, largely due to its exceptional ability to purify and adsorb contaminants. In hospitals, it plays a vital role in maintaining clean air and water, while in pharmaceutical manufacturing, it's used to remove impurities and unwanted colorants from medications. Medical-grade activated carbon, approved for human use, is also a critical tool in emergency medicine for treating poisonings. It works by binding to toxins in the gastrointestinal tract, stopping them from being absorbed into the body, a life-saving measure in cases of overdose or accidental ingestion.

This rising demand is also tied to the significant challenge posed by hospital-acquired infections (HAIs) in the U.S. Each year, approximately 1.7 million patients, roughly 5% to 10% of those hospitalized, develop an HAI, with close to 100,000 resulting deaths. These numbers highlight a serious public health concern that exceeds the impact of many other major diseases. To combat this, healthcare facilities are turning to advanced purification technologies, with activated carbon being a top choice due to its efficiency in filtering harmful particles and pathogens.

In addition, activated carbon is heavily utilized in the pharmaceutical industry for its high porosity and excellent adsorption capabilities, which are enhanced through thermal processing. These properties allow it to effectively remove contaminants, pigments, and residues during drug production, improving the final product's quality and safety.

Activated Carbon For Pharma & Healthcare Market Highlights

  • Based on form, the powdered form dominated the market with the largest revenue share of 56.3% in 2024.
  • The granular activated carbon market for the pharmaceutical and healthcare industry is estimated to grow at the fastest CAGR over the forecast period.
  • Its superior absorption, easy handling, storage, and ability to withstand repeated filtration cycles drive the growth.
  • Based on application, API production led the activated carbon market for the pharma & healthcare industry, accounting for the largest revenue share in 2024.
  • The finished drug production segment is expected to grow at a significant CAGR of 6.2% over the forecast period.
  • Asia-Pacific dominated the global market with the largest revenue share of 48.6% in 2024.
  • The rise in pharmaceutical production across Asian countries fueled the demand for more efficient purification methods during production.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources & Third-Party Perspectives
1.3.4. Primary Research
1.4. Information Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Activated Carbon For Pharma & Healthcare Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related Market Outlook
3.2. Industry Value Chain Analysis
3.3. Regulatory Framework
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.2. Market Restraint Analysis
3.4.3. Industry Challenges
3.4.4. Industry Opportunities
3.5. Industry Analysis Tools
3.5.1. Porter’s Five Forces Analysis
3.5.2. Macro-environmental Analysis
Chapter 4. Activated Carbon For Pharma & Healthcare Market: Form Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Activated Carbon For Pharma & Healthcare Market: Form Movement Analysis & Market Share, 2024 & 2030
4.3. Powdered
4.3.1. Powdered Form Market Revenue Estimates and Forecasts, 2018-2030 (Kilotons, USD Million)
4.4. Granular
4.4.1. Granular Form Market Revenue Estimates and Forecasts, 2018-2030 (Kilotons, USD Million)
4.5. Other Form
4.5.1. Other Form Market Revenue Estimates and Forecasts, 2018-2030 (Kilotons, USD Million)
Chapter 5. Activated Carbon For Pharma & Healthcare Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Activated Carbon For Pharma & Healthcare Market: Application Movement Analysis & Market Share, 2024 & 2030
5.3. API Production
5.3.1. Activated Carbon For Pharma & Healthcare Market Revenue Estimates and Forecasts, in API Production, 2018-2030 (Kilotons, USD Million)
5.4. Finished Drug Production
5.4.1. Activated Carbon For Pharma & Healthcare Market Revenue Estimates and Forecasts, in Finished Drug Production, 2018-2030 (Kilotons, USD Million)
5.5. Others
5.5.1. Activated Carbon For Pharma & Healthcare Market Revenue Estimates and Forecasts, in Other Applications, 2018-2030 (Kilotons, USD Million)
Chapter 6. Activated Carbon For Pharma & Healthcare Market: Regional Estimates & Trend Analysis
6.1. Regional Movement Analysis & Market Share, 2024 & 2030
6.2. North America
6.2.1. North America activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.2.2. U.S.
6.2.2.1. Key country dynamics
6.2.2.2. U.S. activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.2.3. Canada
6.2.3.1. Key country dynamics
6.2.3.2. Canada activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.2.4. Mexico
6.2.4.1. Key country dynamics
6.2.4.2. Mexico activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.3. Europe
6.3.1. Europe activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.3.2. Germany
6.3.2.1. Key country dynamics
6.3.2.2. Germany activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.3.3. UK
6.3.3.1. Key country dynamics
6.3.3.2. UK activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.3.4. France
6.3.4.1. Key country dynamics
6.3.4.2. France activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.3.5. Italy
6.3.5.1. Key country dynamics
6.3.5.2. Italy activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.3.6. Spain
6.3.6.1. Key country dynamics
6.3.6.2. Spain activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.4.2. China
6.4.2.1. Key country dynamics
6.4.2.2. China activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.4.3. India
6.4.3.1. Key country dynamics
6.4.3.2. India activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.4.4. Japan
6.4.4.1. Key country dynamics
6.4.4.2. Japan activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.4.5. South Korea
6.4.5.1. Key country dynamics
6.4.5.2. South Korea activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.4.6. Australia
6.4.6.1. Key country dynamics
6.4.6.2. Australia activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.5. Latin America
6.5.1. Latin America activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.5.2. Brazil
6.5.2.1. Key country dynamics
6.5.2.2. Brazil activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.5.3. Argentina
6.5.3.1. Key country dynamics
6.5.3.2. Argentina activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.6. Middle East & Africa
6.6.1. Middle East & Africa activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.6.2. South Africa
6.6.2.1. Key country dynamics
6.6.2.2. South Africa activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Key country dynamics
6.6.3.2. Saudi Arabia activated carbon for pharma & healthcare market estimates & forecast, 2018-2030 (Kilotons, USD Million)
Chapter 7. Activated Carbon For Pharma & Healthcare Market - Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map
7.4. Position Analysis, 2024
7.5. Strategy Mapping
7.5.1. Expansion
7.5.2. Mergers & Acquisition
7.5.3. Partnerships & Collaborations
7.5.4. New Form Launches
7.5.5. Research And Development
7.6. Company Profiles
7.6.1. Jacobi Group
7.6.1.1. Participant’s overview
7.6.1.2. Financial performance
7.6.1.3. Form benchmarking
7.6.1.4. Recent developments
7.6.2. Chemviron (a Kuraray Company)
7.6.2.1. Participant’s overview
7.6.2.2. Financial performance
7.6.2.3. Form benchmarking
7.6.2.4. Recent developments
7.6.3. Haycarb PLC
7.6.3.1. Participant’s overview
7.6.3.2. Financial performance
7.6.3.3. Form benchmarking
7.6.3.4. Recent developments
7.6.4. Boyce Carbon
7.6.4.1. Participant’s overview
7.6.4.2. Financial performance
7.6.4.3. Form benchmarking
7.6.4.4. Recent developments
7.6.5. Southern Carbon Pvt. Ltd.
7.6.5.1. Participant’s overview
7.6.5.2. Financial performance
7.6.5.3. Form benchmarking
7.6.5.4. Recent developments
7.6.6. Suneeta Carbons
7.6.6.1. Participant’s overview
7.6.6.2. Financial performance
7.6.6.3. Form benchmarking
7.6.6.4. Recent developments
7.6.7. Calgon Carbon Corporation
7.6.7.1. Participant’s overview
7.6.7.2. Financial performance
7.6.7.3. Form benchmarking
7.6.7.4. Recent developments
7.6.8. Karbonous Inc.
7.6.8.1. Participant’s overview
7.6.8.2. Financial performance
7.6.8.3. Form benchmarking
7.6.8.4. Recent developments
7.6.9. Norit
7.6.9.1. Participant’s overview
7.6.9.2. Financial performance
7.6.9.3. Form benchmarking
7.6.9.4. Recent developments
7.6.10. Donau Carbon GmbH
7.6.10.1. Participant’s overview
7.6.10.2. Financial performance
7.6.10.3. Form benchmarking
7.6.10.4. Recent developments
List of Tables
Table 1. List of abbreviations
Table 2. Activated carbon for pharma & healthcare market 2018-2030 (Kilotons) (USD Million)
Table 3. Global activated carbon for pharma & healthcare market estimates and forecasts by form, 2018-2030 (Kilotons) (USD Million)
Table 4. Global activated carbon for pharma & healthcare market estimates and forecasts by application, 2018-2030 (Kilotons) (USD Million)
Table 5. Global activated carbon for pharma & healthcare market estimates and forecasts by region, 2018-2030 (Kilotons) (USD Million)
Table 6. North America activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 7. North America activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 8. North America activated carbon for pharma & healthcare market by country, 2018-2030 (Kilotons) (USD Million)
Table 9. U.S. activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 10. U.S. activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 11. Canada activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 12. Canada activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 13. Mexico activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 14. Mexico activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 15. Europe activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 16. Europe activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 17. Europe activated carbon for pharma & healthcare market by country, 2018-2030 (Kilotons) (USD Million)
Table 18. Germany activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 19. Germany activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 20. UK activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 21. UK activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 22. France activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 23. France activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 24. Italy activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 25. Italy activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 26. Spain activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 27. Spain activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 28. Asia Pacific activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 29. Asia Pacific activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 30. Asia Pacific activated carbon for pharma & healthcare market by country, 2018-2030 (Kilotons) (USD Million)
Table 31. China activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 32. China activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 33. India activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 34. India activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 35. Japan activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 36. Japan activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 37. South Korea activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 38. South Korea activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 39. Australia activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 40. Australia activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 41. Latin America activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 42. Latin America activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 43. Latin America activated carbon for pharma & healthcare market by country, 2018-2030 (Kilotons) (USD Million)
Table 44. Brazil activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 45. Brazil activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 46. Argentina activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 47. Argentina activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 48. Middle East & Africa activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 49. Middle East & Africa activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 50. Middle East & Africa activated carbon for pharma & healthcare market by country, 2018-2030 (Kilotons) (USD Million)
Table 51. South Africa activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 52. South Africa activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
Table 53. Saudi Arabia activated carbon for pharma & healthcare market by form, 2018-2030 (Kilotons) (USD Million)
Table 54. Saudi Arabia activated carbon for pharma & healthcare market by application, 2018-2030 (Kilotons) (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 QFD Modeling for Market Share Assessment
Figure 6 Information Procurement
Figure 7 Market Formulation and Validation
Figure 8 Data Validating & Publishing
Figure 9 Market Segmentation & Scope
Figure 10 Activated Carbon For Pharma & Healthcare Market Snapshot
Figure 11 Form Segment Snapshot (1/2)
Figure 12 Application Segment Snapshot (1/2)
Figure 13 Competitive Landscape Snapshot
Figure 14 Parent market outlook
Figure 15 Activated Carbon For Pharma & Healthcare Market Value, 2024 (Kilotons) (USD Million)
Figure 16 Activated Carbon For Pharma & Healthcare Market - Value Chain Analysis
Figure 17 Activated Carbon For Pharma & Healthcare Market - Market Dynamics
Figure 18 Activated Carbon For Pharma & Healthcare Market - PORTER’s Analysis
Figure 19 Activated Carbon For Pharma & Healthcare Market - PESTEL Analysis
Figure 20 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, By Form: Key Takeaways
Figure 21 Activated Carbon For Pharma & Healthcare Market Share, By Form, 2024 & 2030
Figure 22 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in Powdered Form, 2018-2030 (Kilotons) (USD Million)
Figure 23 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in Granular Form, 2018-2030 (Kilotons) (USD Million)
Figure 24 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, By Application: Key Takeaways
Figure 25 Activated Carbon For Pharma & Healthcare Market Share, By Application, 2024 & 2030
Figure 26 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in API Production, 2018-2030 (Kilotons) (USD Million)
Figure 27 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in Finished Drug Production, 2018-2030 (Kilotons) (USD Million)
Figure 28 Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, in Others, 2018-2030 (Kilotons) (USD Million)
Figure 29 Activated Carbon For Pharma & Healthcare Market Revenue, By Region, 2024 & 2030 (Kilotons) (USD Million)
Figure 30 North America Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 31 U.S. Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 32 Canada Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 33 Mexico Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 34 Europe Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 35 Germany Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 36 UK Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 37 France Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 38 Italy Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 39 Spain Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 40 Asia Pacific Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 41 China Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 42 India Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 43 Japan Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 44 South Korea Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 45 Australia Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 46 Latin America Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 47 Brazil Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 48 Argentina Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 49 Middle East & Africa Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 50 South Africa Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 51 Saudi Arabia Activated Carbon For Pharma & Healthcare Market Estimates & Forecasts, 2018-2030 (Kilotons) (USD Million)
Figure 52 Key Company Categorization
Figure 53 Company Market Positioning
Figure 54 Strategy Mapping

Companies Mentioned

The major companies featured in this Activated Carbon for Pharma & Healthcare market report include:
  • Jacobi Group
  • Chemviron (a Kuraray Company)
  • Haycarb PLC
  • Boyce Carbon
  • Southern Carbon Pvt. Ltd.
  • Suneeta Carbons
  • Calgon Carbon Corporation
  • Karbonous Inc.
  • Norit
  • Donau Carbon GmbH

Table Information

Report AttributeDetails
No. of Pages132
PublishedMay 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 450.1 Million
Forecasted Market Value ( USD ) by 2030 $ 652.1 Million
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

North America Activated Carbon Market Size, Share & Trends Analysis Report By Type (Granular, Powdered), By Form (Liquid, Gas), By End-use (Water Treatment, Air Purification), By Country, And Segment Forecasts, 2024 - 2030 - Product Image

North America Activated Carbon Market Size, Share & Trends Analysis Report By Type (Granular, Powdered), By Form (Liquid, Gas), By End-use (Water Treatment, Air Purification), By Country, And Segment Forecasts, 2024 - 2030

  • Report
  • 105 Pages
  • North America
From
Activated Carbon Market Size, Share & Trends Analysis Report By Form (Powdered, Granular), By Type (Liquid Phase, Gas Phase), By End Use (Water Treatment, Automotive), By Region (North America, Europe), And Segment Forecasts, 2024 - 2030 - Product Image

Activated Carbon Market Size, Share & Trends Analysis Report By Form (Powdered, Granular), By Type (Liquid Phase, Gas Phase), By End Use (Water Treatment, Automotive), By Region (North America, Europe), And Segment Forecasts, 2024 - 2030

  • Report
  • 158 Pages
  • Global
From
Middle East Activated Carbon Market Size, Share & Trends Analysis Report By Source, By Product (Powdered, Granular), By Application, By End-use (Water Treatment, Food & Beverages), And Segment Forecasts, 2023 - 2030 - Product Image

Middle East Activated Carbon Market Size, Share & Trends Analysis Report By Source, By Product (Powdered, Granular), By Application, By End-use (Water Treatment, Food & Beverages), And Segment Forecasts, 2023 - 2030

  • Report
  • 115 Pages
  • Middle East
From
Activated Carbon Market by Type (Powdered Activated Carbon, Granular Activated Carbon), Application (Liquid Phase Application, and Gas Phase Application), End-Use Industry, Raw Material (Coal, Coconut, Wood, Peat), and Region - Forecast to 2030 - Product Image

Activated Carbon Market by Type (Powdered Activated Carbon, Granular Activated Carbon), Application (Liquid Phase Application, and Gas Phase Application), End-Use Industry, Raw Material (Coal, Coconut, Wood, Peat), and Region - Forecast to 2030

  • Report
  • 349 Pages
  • Global
From
Activated Carbon Fiber Market by Type (PAN-based, Pitch-based, Cellulosic Fiber, Phenolic Resin), Application (Solvent Recovery, Air Purification, Water Treatment, Catalyst Carrier), & Region (North America, Europe, APAC, RoW) - Global Forecast to 2027 - Product Image

Activated Carbon Fiber Market by Type (PAN-based, Pitch-based, Cellulosic Fiber, Phenolic Resin), Application (Solvent Recovery, Air Purification, Water Treatment, Catalyst Carrier), & Region (North America, Europe, APAC, RoW) - Global Forecast to 2027

  • Report
  • 184 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.